Genomenon

@genomenon

Powering Evidence-Based Genomics with Mastermind

Ann Arbor, MI
Vrijeme pridruživanja: rujan 2015.

Tweetovi

Blokirali ste korisnika/cu @genomenon

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @genomenon

  1. 4. velj

    is today and we're inspired by our partners & collaborators working everyday to find a cure.

    Poništi
  2. 29. sij

    Make an impact on - one month away! Did you know there are more than 7,000 rare diseases affecting 25-30 million Americans? Learn more about Rare Disease Day and ways to get involved:

    Poništi
  3. 28. sij

    New ! Check out the updates to Mastermind! We continue to far outstrip any other source for genomic evidence - our users can be confident that they are searching the most comprehensive database.

    Poništi
  4. proslijedio/la je Tweet
    24. sij

    Great to be back presenting in the AI and Data Science Showcase!

    Poništi
  5. 24. sij

    Today! Head to the and Data Sciences Showcase Track 2 at 11:15am PST where Genomenon founder & CSO will present 'Curating the Entire Human Genome at Scale' & visit Booth B1002 to learn more about Mastermind 🧬

    Poništi
  6. 23. sij

    Making great connections at Make sure you stop by Booth B1002 to learn about Mastermind - the most comprehensive source of evidence🧬

    Poništi
  7. 22. sij

    Genomenon’s Mastermind Continues to Outpace Qiagen’s HGMD Genetic Database. For to truly advance, and is the only way to provide comprehensive access to the data needed for variant interpretation. The full story:

    Poništi
  8. 21. sij

    Genomenon’s Mastermind® Continues to Outpace Qiagen’s HGMD® Genetic Database Find us at Booth B1002 to learn more about !

    Poništi
  9. proslijedio/la je Tweet
    19. sij

    Good coverage on Genomenon's position in AI by First Analysis - Nice report on Digital Solutions in Pharma Joseph Munda!

    Poništi
  10. 20. sij

    Will we see you at ? Stop by Booth B1002 to try Mastermind for yourself and be sure to see founder and CSO present, 'Curating the Entire Human Genome at Scale' Track 2 - A.I. & Data Sciences Showcase Jan 24 at 11:15am

    Poništi
  11. proslijedio/la je Tweet
    15. sij

    Genomenon CEO explains how Mastermind leverages Artificial intelligence & genomics to drive rare disease drug development at 2020 Digital Medicine & Medtech Showcase at 🧬

    Poništi
  12. 15. sij

    Don't miss Genomenon CEO presenting today at 11:45am PST at 'Leveraging AI & Genomics to Drive Rare Disease Drug Development'.

    Poništi
  13. 13. sij

    “Mastermind is a game-changer for clinical diagnostic labs and companies that diagnose and treat .” Genomenon CEO and CSO are at this week - send us a DM to schedule a meeting.

    Poništi
  14. proslijedio/la je Tweet

    It's not too late to discover how to tackle curating the entire human genome at scale! Join us at January 21-24. Mark Kiel, M.D., Ph.D., , presents Jan 24 at 11:15am, Track 2. Details and Tickets:

    Poništi
  15. 9. sij

    Q1 update to our Cited Variant Reference (CVR) file is ready for download! The CVR is the essential resource for quickly identifying which variants have been cited in the medical literature. Download the most comprehensive variant list available here:

    Poništi
  16. 8. sij

    Excellent expert panel discussion about AI, machine learning & deep learning at BioArbor with

    Poništi
  17. 8. sij

    Join us this evening for BioArbor - Life Science Forum event 'Potential for AI and Machine Learning in Healthcare and Life Sciences' Central Innovation Center. Founder/CTO Steve Schwartz is a featured panelist - info & registration:

    Poništi
  18. proslijedio/la je Tweet
    6. sij

    Catch up with Genomenon at JPM next week

    Poništi
  19. 2. sij

    🧬Happy 2020! Have you seen the latest updates to Mastermind? Via - Mastermind Update Simplifies Searches of Genomic Literature

    Poništi
  20. 27. pro 2019.

    Genomenon Co-Founder & CTO Steve Schwartz will be a panelist at the next Jan 8th Central Innovation Center speaking on: Potential for AI and Machine Learning in Healthcare and Life Sciences.

    , , i još njih 2
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·